Zazove Associates’s IMAX IMAX Stock Holding History

Zazove Associates’s Portfolio IMAX Stock Details IMAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-88,740	Closed	-$1.25M	–	153
2022 Q3	$1.25M	Hold	88,740	–	–	0.11%	98
2022 Q2	$1.5M	Buy	+88,740	New	+$1.44M	0.14%	95

Other funds holding IMAX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Zazove Associates's IMAX Position: Q4 2022 in Review

Zazove Associates sold out of IMAX (IMAX) in Q4 2022, closing a stake of 88,740 shares — an estimated $1.25M sold.

Zazove Associates first reported a position in IMAX in Q2 2022 and held it in 2 quarters. The position peaked at $1.5M in Q2 2022. 139 funds tracked by Wall St. Rank hold IMAX as of Q4 2022.

Zazove Associates reported no remaining IMAX position as of Q4 2022 after selling out during the quarter.
Zazove Associates sold 88,740 IMAX shares in Q4 2022, an estimated $1.25M.
Zazove Associates first reported a position in IMAX in Q2 2022 and held it in 2 quarters.
Zazove Associates's IMAX position peaked at $1.5M in Q2 2022.
139 funds tracked by Wall St. Rank held IMAX as of Q4 2022.

Based on Zazove Associates's 13F filing for Q4 2022, filed 31 Jan 2023.